VEGF in Signaling and Disease: Beyond Discovery and Development

被引:2875
作者
Apte, Rajendra S. [1 ,2 ,3 ]
Chen, Daniel S. [4 ]
Ferrara, Napoleone [5 ,6 ,7 ]
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA
[4] IGM Biosci, Mountain View, CA USA
[5] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA
[6] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA
[7] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; DIABETIC MACULAR EDEMA; VASCULAR-PERMEABILITY FACTOR; OXYGEN-INDUCED RETINOPATHY; FACTOR MONOCLONAL-ANTIBODY; RENAL-CELL CARCINOMA; PHASE-II TRIAL; TYROSINE KINASE; TUMOR VASCULATURE; IN-VITRO;
D O I
10.1016/j.cell.2019.01.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our understanding of vasculogenesis and angiogenesis during development and physiological homeostasis. Over a short span of two decades, our understanding of the molecular mechanisms by which VEGF coordinates neurovascular homeostasis has become more sophisticated. The central role of VEGF in the pathogenesis of diverse cancers and blinding eye diseases has also become evident. Elucidation of the molecular regulation of VEGF and the transformative development of multiple therapeutic pathways targeting VEGF directly or indirectly is a powerful case study of how fundamental research can guide innovation and translation. It is also an elegant example of how agnostic discovery and can transform our understanding of human disease. This review will highlight critical nodal points in VEGF biology, including recent developments in immunotherapy for cancer and multitarget approaches in neovascular eye disease.
引用
收藏
页码:1248 / 1264
页数:17
相关论文
共 206 条
[1]
The role of vascular endothelial growth factor \in ocular health and disease [J].
Adamis, AP ;
Shima, DT .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (02) :111-118
[2]
VASCULAR REACTIONS OF NORMAL AND MALIGNANT TISSUES INVIVO .1. VASCULAR REACTIONS OF MICE TO WOUNDS AND TO NORMAL AND NEOPLASTIC TRANSPLANTS [J].
ALGIRE, GH ;
CHALKLEY, HW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1945, 6 (01) :73-85
[3]
Lymphangiogenesis in development and human disease [J].
Alitalo, K ;
Tammela, T ;
Petrova, TV .
NATURE, 2005, 438 (7070) :946-953
[4]
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation [J].
Allen, Elizabeth ;
Jabouille, Arnaud ;
Rivera, Lee B. ;
Lodewijckx, Inge ;
Missiaen, Rindert ;
Steri, Veronica ;
Feyen, Kevin ;
Tawney, Jaime ;
Hanahan, Douglas ;
Michael, Iacovos P. ;
Bergers, Gabriele .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (385)
[5]
[Anonymous], 1948, Trans. Ophthalmol. Soc. UK
[6]
[Anonymous], 2008, ORGANOGENESIS
[7]
Macrophages inhibit neovascularization in a murine model of age-related macular degeneration [J].
Apte, Rajendra S. ;
Richter, Jennifer ;
Herndon, John ;
Ferguson, Thomas A. .
PLOS MEDICINE, 2006, 3 (08) :1371-1381
[8]
Gene Therapy for Retinal Degeneration [J].
Apte, Rajendra S. .
CELL, 2018, 173 (01) :5-5
[9]
What Is Chronic or Persistent Diabetic Macular Edema and How Should It Be Treated? [J].
Apte, Rajendra S. .
JAMA OPHTHALMOLOGY, 2016, 134 (03) :285-286
[10]
Bevacizumab-Induced Vessel Normalization Hampers Tumor Uptake of Antibodies-Response [J].
Arjaans, Marlous ;
Oosting, Sjoukje F. ;
Schroder, Carolina P. ;
de Vries, Elisabeth G. E. .
CANCER RESEARCH, 2013, 73 (23) :7147-7148